David Hanna

David Hanna has a strong background in sales and business development within the biotechnology industry. David currently serves as the Chief Commercial Officer (CCO) at Intelliseq since 2023. Prior to this, they worked at Thermo Fisher Scientific from 2019 to 2023, where they held the position of Director of Global Sales and Business Development, overseeing the use of microarrays for preventive/predictive medicine programs. David was responsible for developing a network of service lab and clinical reporting partners to provide integrated healthcare solutions.

Before joining Thermo Fisher Scientific, Hanna worked at Affymetrix for a significant portion of their career, from 2002 to 2019. David held various roles during their time at the company, including Director of Genotyping Sales for the Americas region, Senior District Sales Manager for the Southeast, and National Accounts Manager. David'sresponsibilities included achieving sales targets and managing key accounts.

Prior to their tenure at Affymetrix, Hanna worked at Incyte Genomics as a Key Account Executive/Client Business Manager from 2001 to 2002. David also served as a Sales Engineer at Packard BioScience (now part of Perkin Elmer) from 1999 to 2001 and as a Technical Sales Representative at Stratagene from 1996 to 1999.

David Hanna attended The University of Texas at Austin, where they obtained their BA in Biochemistry. After completing their undergraduate studies, they pursued further education at The University of Georgia, where they earned their Ph.D. in Biochem/Genetics. Following their doctoral degree, David Hanna conducted postdoctoral research at The Johns Hopkins University, focusing on Genetics.